Publication: Antiarrhythmic drugs-clinical use and clinical decision making: A consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
dc.contributor.author | Dan, Gheorghe-Andrei (6701679438) | |
dc.contributor.author | Martinez-Rubio, Antoni (55663792400) | |
dc.contributor.author | Agewall, Stefan (7006435302) | |
dc.contributor.author | Boriani, Giuseppe (57675336900) | |
dc.contributor.author | Borggrefe, Martin (35380094100) | |
dc.contributor.author | Gaita, Fiorenzo (56233008400) | |
dc.contributor.author | Van Gelder, Isabelle (7006440916) | |
dc.contributor.author | Gorenek, Bulent (7004714353) | |
dc.contributor.author | Kaski, Juan Carlos (57202841331) | |
dc.contributor.author | Kjeldsen, Keld (7007013632) | |
dc.contributor.author | Lip, Gregory Y. H. (57216675273) | |
dc.contributor.author | Merkely, Bela (7004434435) | |
dc.contributor.author | Okumura, Ken (56725883100) | |
dc.contributor.author | Piccini, Jonathan P. (8513824700) | |
dc.contributor.author | Potpara, Tatjana (57216792589) | |
dc.contributor.author | Poulsen, Birgitte Klindt (55349080700) | |
dc.contributor.author | Saba, Magdi (12773877200) | |
dc.contributor.author | Savelieva, Irina (6701768664) | |
dc.contributor.author | Tamargo, Juan L. (35315133900) | |
dc.contributor.author | Wolpert, Christian (7005239833) | |
dc.date.accessioned | 2025-06-12T16:25:17Z | |
dc.date.available | 2025-06-12T16:25:17Z | |
dc.date.issued | 2018 | |
dc.description.abstract | [No abstract available] | |
dc.identifier.uri | https://doi.org/10.1093/europace/eux373 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046986580&doi=10.1093%2feuropace%2feux373&partnerID=40&md5=75843d009ae6413640f97d4ab2e79b0a | |
dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/6331 | |
dc.subject | Antiarrhythmic drugs | |
dc.subject | Arrhythmias | |
dc.subject | Atrial fibrillation | |
dc.subject | Bradycardia | |
dc.subject | EHRA consensus document | |
dc.subject | Extrasystoles | |
dc.subject | Pre-excitation | |
dc.subject | Proarrhythmias | |
dc.subject | Sudden cardiac death | |
dc.subject | Supraventricular arrhythmias | |
dc.subject | Ventricular tachycardia | |
dc.title | Antiarrhythmic drugs-clinical use and clinical decision making: A consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP) | |
dspace.entity.type | Publication |